Simon Pedder
Chief Executive Officer at Nirogy Therapeutics, Inc.
Network origin in Simon Pedder first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
19
| Private Company | Pharmaceuticals: Major | 19 |
| Public Company | Pharmaceuticals: Major | 17 | |
Novelos Therapeutics, Inc.
 Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI.
14
| Extinct | Pharmaceuticals: Major | 14 |
| Subsidiary | Biotechnology | 10 | |
Ivory Capital Corp.
9
| Extinct | Financial Conglomerates | 9 |
Atlantic Research Group, Inc.
 Atlantic Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Atlantic Research Group, Inc. operates as a rare disease-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. It offers strategic consulting, clinical trial management services, clinic data and analytics solutions, pharmacovigilance and medical monitoring. The company was founded by Paul Bishop and Lyle Camblos in 2004 and is headquartered in Charlottesville, VA.
7
| Private Company | Miscellaneous Commercial Services | 7 |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022.
6
| Holding Company | Biotechnology | 6 |
| Public Company | Pharmaceuticals: Major | 6 | |
| Public Company | Biotechnology | 5 | |
Chelsea Therapeutics, Inc.
3
| Extinct | Pharmaceuticals: Major | 3 |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Eboo Pharmaceuticals, Inc.
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Simon Pedder via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| VIOQUEST PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director/Board Member | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member President | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | Director/Board Member Chief Tech/Sci/R&D Officer | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Operating Officer | |
GCL Solar Energy Technology Holdings, Inc.
 GCL Solar Energy Technology Holdings, Inc. SemiconductorsElectronic Technology GCL Solar Energy Technology Holdings, Inc. manufactures and sells polysilicon and wafers. Its products are used to produce semiconductors and photovoltaic (PV) solar cells. The company was founded in 2006 and is headquartered in Hong Kong, Hong Kong | Semiconductors | Director/Board Member Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chairman Chairman | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Doctorate Degree | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Medicine & Dentistry of New Jersey | College/University | Chairman Director/Board Member | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Masters Business Admin | |
| University of Hong Kong | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Saskatchewan | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Wisconsin | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Director/Board Member Corporate Officer/Principal Comptroller/Controller/Auditor Director of Finance/CFO | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
TomoTherapy, Inc.
 TomoTherapy, Inc. Medical SpecialtiesHealth Technology TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI. | Medical Specialties | Director/Board Member Founder Comptroller/Controller/Auditor | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| SAGENT PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
| University of Wisconsin Carbone Cancer Center | Corporate Officer/Principal Director/Board Member | ||
Alpha Omega Alpha Honor Medical Society
 Alpha Omega Alpha Honor Medical Society Miscellaneous Commercial ServicesCommercial Services Alpha Omega Alpha Honor Medical Society is a national medical honor society founded in 1902. The non-profit company is based in Menlo Park, CA. The society's mission is to foster the development of the next generation of medical researchers by recognizing high educational achievement, honoring gifted teaching, encouraging the development of leaders in academia and the community, and supporting the improvement of care for all. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
China Lumena New Materials Corp.
 China Lumena New Materials Corp. Chemicals: SpecialtyProcess Industries China Lumena New Materials Corp. operates as an investment holding company, which engages in in the processing and sale of thenardite products. It offers powder, specialty, and medical thenardite. The firm also manufactures and sells polyphenylene sulfide (PPS) products including PPS resin, PPS fibre, and PPS compounds. The company was founded by Duo Ji Suo Lang on April 12, 2007 and is headquartered in Hong Kong. | Chemicals: Specialty | Director/Board Member Director/Board Member |
Statistics
International
| United States | 40 |
| Canada | 4 |
| Hong Kong | 4 |
| France | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 474 |
| Corporate Officer/Principal | 216 |
| Independent Dir/Board Member | 156 |
| Chairman | 115 |
| Chief Executive Officer | 76 |
Most connected contacts
| Insiders | |
|---|---|
| Tiong Lu Koh | 42 |
| Tamar Howson | 41 |
| Garry Neil | 38 |
| Isaac Blech | 32 |
| Sol Barer | 32 |
| Peter Greenleaf | 31 |
| Robert Spiegel | 30 |
| Kam Chung Leung | 29 |
| James Manuso | 29 |
| Bobby Sandage | 29 |
| Paul Berns | 28 |
| Yiu Nam Lau | 26 |
| Michael Weiser | 26 |
| David Tanen | 25 |
| John Niederhuber | 25 |
- Stock Market
- Insiders
- Simon Pedder
- Company connections
